Inventor · disambiguated record
Robert H. Silverman
Also filed as: SILVERMAN ROBERT · SILVERMAN ROBERT H · SILVERMAN ROBERT HUGH
16 granted patents·11 pending applications·558 citations·filing 1993–2018
94Inventor score
Files withCLEVELAND CLINIC FOUNDATION13SILVERMAN ROBERT H3US HEALTH2ABU-KHABAR KHALID S1CLEVELAND CLINIC FOUINDATION A1
Top patents by PatentIndex Score
27 records- 0193US6214805B1RNase L activators and antisense oligonucleotides effective to treat RSV infectionsUS HEALTH·Filed 1997·Granted Apr 10, 2001·174 cites·15 claims
- 0286US5998602ARNase L activators and antisense oligonucleotides effective to treat RSV infectionsCLEVELAND CLINIC FOUINDATION A·Filed 1997·Granted Dec 7, 1999·103 cites·7 claims
- 0382US6331396B1Arrays for identifying agents which mimic or inhibit the activity of interferonsCLEVELAND CLINIC FOUNDATION·Filed 1999·Granted Dec 18, 2001·107 cites·8 claims
- 0481US5583032AMethod of cleaving specific strands of RNACLEVELAND CLINIC FOUNDATION AN·Filed 1993·Granted Dec 10, 1996·56 cites·21 claims
- 0575US5677289AMethod of cleaving specific strands of RNA and medical treatments therebyCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Oct 14, 1997·22 cites·11 claims
- 0672US6468983B2RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignanciesCLEVELAND CLINIC FOUNDATION·Filed 1998·Granted Oct 22, 2002·32 cites·29 claims
- 0767US2009075830A1System for identifying and analyzing expression of are-containing genesCLEVELAND CLINIC FOUNDATION·Filed 2008·Application pending·0 cites
- 0864US6271369B1Chimeric molecules targeted to viral RNAsUS HEALTH·Filed 1997·Granted Aug 7, 2001·15 cites·9 claims
- 0963US5866787ATransgenic plants co-expressing a functional human 2-5A systemCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Feb 2, 1999·21 cites·16 claims
- 1061US2009023592A1System for identifying and analyzing expression of are-containing genesABU-KHABAR KHALID S·Filed 2007·Application pending·0 cites
- 1157US5861300AAntiviral transgenic plants, vectors, cells and methodsCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Jan 19, 1999·12 cites·10 claims
- 1255US2004023231A1System for identifying and analyzing expression of are-containing genesFiled 2001·Application pending·0 cites
- 1355US2010184015A1Method for detection of xmrvSILVERMAN ROBERT H·Filed 2009·Application pending·0 cites
- 1449US8263085B2Gammaretrovirus associated with cancerSILVERMAN ROBERT H·Filed 2007·Granted Sep 11, 2012·0 cites·6 claims
- 1549US5866781AAntiviral transgenic plants, vectors, cells and methodsCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Feb 2, 1999·7 cites·6 claims
- 1645US2019002585A1Cancer treatment methods and compositionsCLEVELAND CLINIC FOUND·Filed 2018·Application pending·0 cites
- 1744US2003104574A1Mutant cell lines and methods for producing enhanced levels of recombinant proteinsFiled 2003·Application pending·0 cites
- 1843US2013040369A1Gammaretrovirus Associated With CancerUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 1942US2002137905A1Phospholipid Scramblases and methods of use thereofFiled 2001·Application pending·0 cites
- 2042US2003203356A1RNase L activator-antisense complexesCLEVELAND CLINIC FOUNDATION·Filed 2003·Application pending·0 cites
- 2139US6762038B1Mutant cell lines and methods for producing enhanced levels of recombinant proteinsCLEVELAND CLINIC FOUNDATION·Filed 1999·Granted Jul 13, 2004·2 cites·12 claims
- 2239US5972678AAnimal 2-5A dependent RNasesCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Oct 26, 1999·3 cites·7 claims
- 2338US6028243AMice and cells with a homozygous disruption in the RNase L gene and methods thereforeCLEVELAND CLINIC FOUNDATION·Filed 1997·Granted Feb 22, 2000·3 cites·14 claims
- 2438US2011151431A1Detection of xenotropic murine leukemia virusWHITTEMORE PETERSON INST FOR NEURO IMMUNE DISEASE·Filed 2010·Application pending·0 cites
- 2536US2012251571A1Rnase l-mediated cleavage products and uses thereofSILVERMAN ROBERT H·Filed 2011·Application pending·0 cites
- 2631US5877019AAnimal 2-5A-dependent RNases and encoding sequences thereforCLEVELAND CLINIC FOUNDATION·Filed 1996·Granted Mar 2, 1999·1 cites·16 claims
- 2727US5840577AAnimal 2-5A-dependent RNases and encoding sequences thereforCLEVELAND CLINIC FOUNDATION·Filed 1995·Granted Nov 24, 1998·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Robert H. Silverman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →